Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine

NCT03300050 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Influenza
Vaccine

Interventions

BIOLOGICAL: cH8/1N1 LAIV
BIOLOGICAL: AS03-adjuvanted cH5/1N1 IIV
BIOLOGICAL: cH5/1N1 IIV
BIOLOGICAL: AS03-adjuvanted cH8/1N1 IIV
BIOLOGICAL: Normal saline
BIOLOGICAL: Phosphate buffered saline (PBS)

Sponsor

PATH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]